A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
Clinical trial NCT06132217 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06132217
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2027-01-30
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.